Skip to main content
Livermore
Livermore
ZHEN

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.

Holders of 5% or more of NSPR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of InspireMD, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NSPR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Marshall Wace, LLP13G/A9.99%28.1M shares–Nov 14, 20251 filingNov 14, 2025SEC
Nantahala Capital Management, LLC13G/A9.99%4.26M shares0.00 ppfrom 9.99%Nov 14, 20244 filingsNov 14, 2025SEC
Rosalind Advisors, Inc.13G/A9.90%11.0M shares+0.50 ppfrom 9.40%Feb 7, 20255 filingsAug 11, 2025SEC
Lawless Michael A13D8.60%3.61M sharesNewOct 29, 20251 filingOct 29, 2025SEC
Standard Life Aberdeen plc13G5.95%2.48M sharesNewNov 7, 20251 filingNov 7, 2025SEC
Parkman Healthcare Partners LLC13G5.80%2.44M sharesNewNov 14, 20251 filingNov 14, 2025SEC
Nantahala Capital Partners Limited Partnership13G/A5.68%2.42M shares–Nov 14, 20251 filingNov 14, 2025SEC
Velan Capital Investment Management LP13G5.10%2.14M sharesNewAug 6, 20251 filingAug 6, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

18 Schedule 13D and 13G filings on InspireMD, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NSPR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20256:12 PM ETOrbiMed Advisors LLC13G/A4.10%2.13M shares−3.10 ppfrom 7.20%Below 5%Sep 30, 2025SEC
Nov 14, 20254:47 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%4.26M shares0.00 ppfrom 9.99%Sep 30, 2025SEC
Nov 14, 20254:31 PM ETNantahala Capital Partners Limited Partnership13G/A5.68%2.42M shares–Sep 30, 2025SEC
Nov 14, 20254:22 PM ETMarshall Wace, LLP13G/A9.99%28.1M shares–Sep 30, 2025SEC
Nov 14, 202512:44 PM ETParkman Healthcare Partners LLCand 3 others13G5.80%2.44M sharesNewSep 30, 2025SEC
Nov 7, 20256:25 AM ETStandard Life Aberdeen plcand 1 other13G5.95%2.48M sharesNewOct 1, 2025SEC
Oct 29, 20254:30 PM ETShore Craig13D/A3.50%1.48M shares–Below 5%Jun 26, 2025SEC
Oct 29, 20254:30 PM ETLawless Michael A13D8.60%3.61M sharesNewJun 26, 2025SEC
Aug 11, 20252:39 PM ETRosalind Advisors, Inc.and 4 others13G/A9.90%11.0M shares+0.50 ppfrom 9.40%Aug 1, 2025SEC
Aug 11, 202511:32 AM ETRosalind Advisors, Inc.and 4 others13G/A9.40%11.0M shares0.00 ppfrom 9.40%Aug 1, 2025SEC
Aug 11, 202511:20 AM ETRosalind Advisors, Inc.and 4 others13G/A9.40%11.0M shares+1.70 ppfrom 7.70%Mar 31, 2025SEC
Aug 6, 20254:06 PM ETVelan Capital Investment Management LPand 5 others13G5.10%2.14M sharesNewJul 30, 2025SEC
May 15, 20258:13 PM ETOrbiMed Advisors LLCand 1 other13G/A7.20%2.13M shares–Mar 31, 2025SEC
May 15, 20254:32 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%3.04M shares0.00 ppfrom 9.99%Mar 31, 2025SEC
May 12, 20251:44 PM ETRosalind Advisors, Inc.and 4 others13G/A7.70%9.71M shares−2.20 ppfrom 9.90%Mar 31, 2025SEC
Feb 14, 20254:32 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%2.71M shares0.00 ppfrom 9.99%Dec 31, 2024SEC
Feb 7, 202511:24 AM ETRosalind Advisors, Inc.and 4 others13G/A9.90%9.93M shares–Dec 31, 2024SEC
Nov 14, 20244:53 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%2.61M shares–Sep 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell InspireMD, Inc. shares.

No Form 144 notices for InspireMD, Inc. are on file.